Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: The Korean Cancer Study Group ST14-11
Gastric Cancer Jan 30, 2018
Kim HS, et al. - The efficacy and safety of the combination of irinotecan, oxaliplatin, and S-1 (OIS) for the treatment of advanced gastric cancer were evaluated in this study. In patients with advanced gastric cancer, the OIS regimen was effective and relatively well tolerated. All the treated patients had a good performance status, except 1.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
